Deal type reports
-
Royalty Rates in Pharmaceutical and Biotechnology DealsSeptember 2024$3,995.00Essential Benchmark Data for Dealmakers | Global coverage | Updated to 2024 | Over a decade of royalty rates | Deal financials | Contract documents | Royalty rate trends
Learn More -
Distribution Deals in Diagnostics 2016-2024September 2024$3,995.00Distribution Deals in Diagnostics | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Comprehensive deal directory 2016 to 2024
Learn More -
Licensing Deals in Biotechnology 2019-2024September 2024$3,995.00Licensing Deals in Biotechnology | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Comprehensive deal directory 2019 to 2024
Learn More -
Collaboration Deals in Biotechnology 2019-2024September 2024$3,995.00Collaboration Deals in Biotechnology | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Comprehensive deal directory 2019 to 2024
Learn More -
Distribution Deals in Medical Devices 2016-2024September 2024$3,995.00Distribution Deals in Medical Devices | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Comprehensive deal directory 2016 to 2024
Learn More -
Co-promotion and Co-marketing Deals in Pharmaceuticals and Biotechnology 2016-2024September 2024$3,995.00Co-promotion and Co-marketing Deals in Pharmaceuticals and Biotechnology | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Comprehensive deal directory 2016 to 2024
Learn More -
Merger and Acquisition (M&A) Deals in Pharmaceuticals, Biotechnology and Diagnostics 2020-2024August 2024$3,995.00Global coverage | Deal financials | Contract documents | Deal trends | Leading M&A dealmakers | Comprehensive deal directory 2020 to 2024
Learn More
